Low-field (0.35 T) magnetic resonance imaging guided radiation therapy (MR-IGRT) was used for the first time to treat a patient with a cardiovascular implantable electronic device (CIED) and a cardiac fibroma located on the left ventricle. Stereotactic body radiation therapy (SBRT) was delivered in 5 fractions at a dose of 700 cGy/fraction with MRI-based real-time tumor tracking and beam gating. Lessons learned include the need for metal artifact suppression, higher MRI temporal resolution, and MRI safety workflows adapted to radiation oncology.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords